• Mar. Dic 3rd, 2024

meeting

  • Home
  • Estrogen-Only Hormone Therapy may increase cancer risk while Estrogen-Progestin Combination may lower risk #ASCO24

Estrogen-Only Hormone Therapy may increase cancer risk while Estrogen-Progestin Combination may lower risk #ASCO24

For people who have been through menopause and have taken menopausal hormone therapy, conjugated equine estrogen (CEE) taken alone may increase the risk of developing and dying from ovarian cancer,…

TUMORE AL SENO, SI DIVENTA MAMMA ANCHE DOPO LA TERAPIA #ASCO24

La maggior parte delle sopravvissute al cancro al seno dallo stadio 0 allo stadio III che cercano di concepire, dopo aver completata la terapia, sono in grado di rimanere incinte…

Studies on risks of weight-loss drugs #DDW2024

Studies examining the risks of GLP-1 weight-loss drugs, distinguishing alpha-gal syndrome from other GI disorders, and comparing medications to slow the progression of liver disease in patients with alcohol-use disorder…

Hunger hormone, antibiotic-induced weight gain, and sleep and digestive health explored at Digestive Disease Week #DDW2024

Studies featuring endoscopic and laparoscopic procedures, including patient views on artificial intelligence in endoscopy and hazards to healthcare personnel of smoke-producing procedures, will be presented this week at Digestive Disease…

For younger women, mental health now may predict heart health later #AAC24

Younger women are generally thought to have a low risk of heart disease, but new research urges clinicians to revisit that assumption, especially for women who suffer from certain mental…